May 28, 2019 - Tough industry conditions took their toll on some stocks.
May 28, 2019 - A larger-than-expected legal settlement might be a harbinger of things to come.
May 28, 2019 - Teva Pharmaceutical Industries (TEVA -12.9%) commences the U.S. commercial launch of its generic version of Gilead Sciences' (GILD -3.2%) angina med Ranexa (ranolazine) Extended-Release Tablets, 500 m
May 28, 2019 - Oklahoma state prosecutors blasted J&J in the first day of a landmark opioid trial Tuesday, saying it ran a "deceitful, multibillion-dollar brainwashing campaign" that led to more than 46,000 deaths in the state over a decade.
May 28, 2019 - Gainers: Soliton (NASDAQ:SOLY) +80%. Biocept (NASDAQ:BIOC) +25%. Armata Pharmaceuticals (NYSEMKT:ARMP) +16%. OncoSec Medical (NASDAQ:ONCS) +15%. MYnd Analytics (NASDAQ:MYND) +10%.Losers: Kezar Life Sc
May 28, 2019 - Without admitting any wrongdoing, Teva Pharmaceutical Industries (NYSE:TEVA) has agreed to settle claims by the U.S. state of Oklahoma over its role in the opioid crisis there via a one-time payment o
May 26, 2019 - Teva Pharmaceutical (NYSE:TEVA) has agreed to an $85M settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the
May 26, 2019 - One of the drugmakers named in Oklahoma's lawsuit over the opioid crisis has agreed to a settlement in which it will pay the state $85 million.
May 22, 2019 - Orbimed Advisors Llc Buys Neurocrine Biosciences Inc, Teva Pharmaceutical Industries, Endo International PLC, Sells Biogen Inc, Celgene Corp, Allergan PLC, Stocks: NBIX,EW,MGTX,BMY,MYOK,APLS,TEVA,ENDP,PRTA,CDNA,CBA, release date:May 22, 2019
May 22, 2019 - Which of these fallen stars has the more compelling comeback story?